Forum Relief therapeutics geopend
ABOUT US
Relief is a biopharmaceutical company founded by former Merck executives (Serono division) whose objective is to provide patients with therapeutic relief in serious diseases with high unmet medical need.
We focus on clinical-stage programs based on molecules of natural origin (peptides and proteins) with a history of clinical use (well-established safety and tolerability) and either initial human activity with efficacy data (proof-of-concept) or a strong scientific rationale. Our most advanced programs involve our lead compound RLF-100™, a synthetic human vasoactive intestinal peptide (VIP) with multifaceted mode of action, in respiratory indications: COVID-19 induced lung injury with major near-term milestones and pulmonary sarcoidosis, two diseases for which no transformational therapy exists. Clinical development of RLF-100™ for other indications in both acute and chronic lung diseases are in planning stages.
Groet Henk
Dag Henk,
Relief Therapeutics Holding AG juni 2020 is een bestaand forum .
Komt er een pré en post EUA ;-)
Of is dit het forum voor de ZWR alleen ?
Direct naar Forum
Detail
| Vertraagd |
2 jun 2023 17:30 |
| Koers |
3,840 |
| Verschil |
+0,040 (+1,05%) |
| Hoog |
3,890 |
| Laag |
3,700 |
| Volume |
20.508 |
| Volume gemiddeld |
3.483.534 |
| Volume gisteren |
28.535 |